Published January 9, 2018

The Epilepsy Unit of the Western Infirmary in Glasgow, Scotland published a study recently that looked at 1,795 men, women, and children who were newly treated for epilepsy between July 1, 1982, and October 31, 2012. They looked at all of the various drugs and drug combinations that doctors used to treat these patients. They said, “Despite the availability of many new anti-epilepsy drugs with differing mechanisms of action, overall outcomes in newly diagnosed epilepsy have not improved. More than one-third of patients experience epilepsy that remains uncontrolled.” They compared their new data with a study that was published 17 years ago. Despite the fact that over a dozen new anti-epilepsy drugs have been put on the market since then, the results were no better. The prices have sky rocketed, the side effects have increased, but the results are the same.

Read More

Published January 6, 2018

Monash University's Biomedicine Discovery Institute scientists have defined a novel molecular “blueprint” that plays a pivotal part in the immune system's ability to fight disease by “remembering” infections.

Read More

Published January 4, 2018

Researchers identified nearly 40,000 cancer patients who had received opioid prescriptions following surgery intended to eradicate the cancer. Doctors generally expect patients to take these drugs for no more than two weeks after surgery. But the study found that three months after surgery, 10% of the patients were continuing to take high levels of opioids. Those who received chemotherapy after the surgery had an even greater risk, with 15% to 21% continuing to take high doses longer than recommended.

Read More